Skip to main content

Table 2 Unit costs of antiretroviral agents

From: Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Antiretroviral agent Cost (€)
FDCs  
AtriplaTM (TDF / emtricitabine / efavirenz: 245 / 200 / 600 mg), 30 tablets 701.08
CombivirTM (zidovudine / lamivudine: 300 / 150 mg), 60 tablets 290.41
KaletraTM (lopinavir / ritonavir: 200 / 50 mg), 120 tablets 400.02
KivexaTM (lamivudine / abacavir: 300 / 600 mg), 30 tablets 355.54
TrizivirTM (zidovudine / lamivudine / abacavir: 300 / 150 / 300 mg), 60 tablets 490.32
TruvadaTM (TDF / emtricitabine: 200 / 245 mg), 30 tablets 432.73
Individual antiretroviral components of FDCs  
Generic lamivudine (300 mg), 30 tablets 62.76
SustivaTM (efavirenz: 600 mg), 30 tablets 265.03
VireadTM (TDF: 250 mg), 30 tablets 288.70
ZiagenTM (abacavir: 300 mg), 60 tablets 225.69
Generic zidovudine (300 mg), 300 tablets 403.15
Other antiretroviral agents employed in addition to FDCs  
IntelenceTM (etravirine: 100 mg), 120 tablets 450.00
IsentressTM (raltegravir: 400 mg), 60 tablets 690.00
NorvirTM (ritonavir: 100 mg), 30 tablets 22.46
PrezistaTM (darunavir: 400 mg), 60 tablets 427.21
ReyatazTM (atazanavir: 200 mg), 60 tablets 436.59
ReyatazTM (atazanavir: 300 mg), 30 tablets 436.59
TelzirTM (fosamprenavir: 700 mg), 60 tablets 316.89
ViramuneTM (nevirapine: 200 mg), 60 tablets 199.69
  1. Ex-factory price (€, 2011).